Acumen Pharmaceuticals, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
0.00 |
0.00 |
0.00 |
0.00 |
26.53 |
56.19 |
| Przychód Δ r/r |
0.00% |
0.00% |
0.00% |
0.00% |
inf% |
111.80% |
| Przychód (min) |
0.00 |
0.00 |
0.00 |
0.00 |
26.53 |
56.19 |
| Przychód (max) |
0.00 |
0.00 |
0.00 |
0.00 |
26.53 |
56.19 |
| EBITDA (średnia) |
0.00 |
0.00 |
0.00 |
0.00 |
15.92 |
33.71 |
| EBIT (średnia) |
0.00 |
0.00 |
0.00 |
0.00 |
15.92 |
33.71 |
| EBIT % |
0.00% |
0.00% |
0.00% |
0.00% |
60.00% |
60.00% |
| Zysk netto (średni) |
-97.50 |
-119.99 |
-100.00 |
-84.45 |
-129.63 |
-121.83 |
| Zysk netto % |
-inf% |
-inf% |
-inf% |
-inf% |
-488.61% |
-216.81% |
| EPS (średnia) |
-1.60 |
-2.00 |
-1.65 |
-1.41 |
-2.16 |
-2.03 |
| Liczba analityków (Przychody) |
0 |
0 |
0 |
0 |
1 |
1 |
| Liczba analityków (EPS) |
4 |
4 |
4 |
1 |
1 |
1 |
| symbol |
ABOS |
ABOS |
ABOS |
ABOS |
ABOS |
ABOS |